<![CDATA[GLP-1 Agonists Address Metabolic Risk in Psoriatic Disease]]>

Дата публикации: 16-10-2026 19:30:00

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	<![CDATA[GLP-1 Candidacy and Prescribing Considerations in Psoriasis]]>	0	10.41	19-10-2026
2	<![CDATA[Anti-Inflammatory Effects of GLP-1 Medications in Psoriasis and Obesity]]>	0	13.38	19-10-2026
3	<![CDATA[Securing GLP-1 Access and Exploring Hidradenitis Suppurativa Trials]]>	0	11.63	20-10-2026
4	<![CDATA[Fall Clinical 2026: The Data and Expert Advice Shaping Dermatology Practice]]>	0	13.68	20-10-2026
5	Direct Coronary Vascular and Lipidomic Remodeling by Low-Dose GLP-1 Agonist Therapy in Cardiometabolic HFpEF	0	20	11-08-2026
6	Dispelling Myths Around GLP-1 Medications	0	9.15	24-09-2026
7	GLP-1s may lower risk for death, heart events among people with hidradenitis suppurativa	5	7	08-07-2026
8	Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review]	0	13.63	08-08-2026
9	Different GLP-1 therapies could be tailored to patients' individual metabolic needs	0	7.25	27-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.43. Источник: www.dermatologytimes.com.